{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:39:44Z","timestamp":1782725984315,"version":"3.54.5"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de n\u00edvel Superior (CAPES)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["#446455\/2014-8, #306824\/2013-2"],"award-info":[{"award-number":["#446455\/2014-8, #306824\/2013-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"publisher","award":["#2012-2551\/13-8"],"award-info":[{"award-number":["#2012-2551\/13-8"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.pnpbp.2015.10.008","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:12:19Z","timestamp":1445904739000},"page":"201-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Involvement of monoaminergic system in the antidepressant-like effect of (octylseleno)-xylofuranoside in the mouse tail suspension test"],"prefix":"10.1016","volume":"65","author":[{"given":"Lucimar M.","family":"Pinto Brod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana G.","family":"Fronza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline Pinto","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo S.","family":"L\u00fcdtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"Luchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel Antunes","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucielli","family":"Savegnago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2015.10.008_bb0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1248\/cpb.54.281","article-title":"Regulation of melanin synthesis by selenium-containing carbohydrates","volume":"54","author":"Ahn","year":"2006","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2012.09.006","article-title":"Serotonin receptors involved in antidepressant effects","volume":"137","author":"Artigas","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0020","doi-asserted-by":"crossref","first-page":"609421","DOI":"10.1155\/2012\/609421","article-title":"Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder","volume":"2012","author":"Behr","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tet.2010.03.033","article-title":"Synthesis of 5\u2032-seleno-xylofuranosides","volume":"66","author":"Braga","year":"2010","journal-title":"Tetrahedron"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004850-200307000-00001","article-title":"Noradrenaline in mood and anxiety disorders: basic and clinical studies","volume":"18","author":"Brunello","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pbb.2014.08.002","article-title":"Serotonergic systems are implicated in antinociceptive effect of m-trifluoromethyl diphenyl diselenide in the mouse glutamate test","volume":"125","author":"Br\u00fcning","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pnpbp.2008.11.007","article-title":"Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium","volume":"33","author":"Cardoso","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb9995","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.2042-7158.1993.tb05578.x","article-title":"Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced swimming test in mice","volume":"45","author":"Cesana","year":"1993","journal-title":"J. Pharm. Pharmacol"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0050","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1517\/13543784.16.9.1365","article-title":"Triple uptake inhibitors: therapeutic potential in depression and beyond","volume":"16","author":"Chen","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb9910","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3945\/jn.114.198010","article-title":"Optimal serum selenium concentrations are associated with lower depressive symptoms and negative mood among young adults.","volume":"145","author":"Conner","year":"2015","journal-title":"J. Nutr."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0060","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.pnpbp.2008.09.006","article-title":"Interaction of zinc with antidepressants in the tail suspension test","volume":"32","author":"Cunha","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1472-8206.2004.00287.x","article-title":"Dopamine, depression and antidepressants","volume":"18","author":"Dailly","year":"2004","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0070","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/00003495-200868050-00011","article-title":"Bupropion: a review of its use in the management of major depressive disorder","volume":"68","author":"Dhillon","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.lfs.2013.07.024","article-title":"Involvement of the dopaminergic and serotonergic systems in the antidepressant-like effect caused by 4-phenyl-1-(phenylselanylmethyl)-1,2,3-triazole","volume":"93","author":"Donato","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(06)67964-6","article-title":"Recent developments and current controversies in depression","volume":"367","author":"Ebmeier","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0090","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","article-title":"Central monoamines and their role in major depression","volume":"28","author":"Elhwuegi","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0095","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s11064-007-9289-x","article-title":"Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain","volume":"32","author":"Eren","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/FBP.0b013e3283123c98","article-title":"Antidepressant-like effects of N-acetyl-L-cysteine in rats","volume":"19","author":"Ferreira","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2014.04.033","article-title":"ERK1\/2 phosphorylation is involved in the antidepressant-like action of 2,5-diphenyl-3-(4-fluorophenylseleno)-selenophene in mice","volume":"736","author":"Gai","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pbb.2012.03.016","article-title":"In vitro antioxidant activity and in vivo antidepressant-like effect of - (phenylselanyl) acetophenone in mice","volume":"102","author":"Gerzson","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0120","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2174\/1568026023393787","article-title":"Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists","volume":"2","author":"Glennon","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression and strategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-3223(95)00085-2","article-title":"Effects of dietary selenium on mood in healthy men living in a metabolic research unit","volume":"2","author":"Hawkes","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neubiorev.2005.06.007","article-title":"Serotonergic modulation of the limbic system","volume":"30","author":"Hensler","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2007.01.063","article-title":"Involvement of dopamine D1 receptors and \u03b11-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test","volume":"562","author":"Hirano","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2009.04.010","article-title":"Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type","volume":"1281","author":"Ishrat","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2010.03.019","article-title":"Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of bis selenide in the mouse tail suspension test","volume":"635","author":"Jesse","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","article-title":"The epidemiology of depression across cultures","volume":"34","author":"Kessler","year":"2013","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0160","first-page":"752563","article-title":"Roles of PI3K\/AKT\/GSK3\/mTOR pathway in cell signaling of mental illnesses","volume":"2012","author":"Kitagishi","year":"2012","journal-title":"Depress. Res. Treat."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-3565(25)27497-3","article-title":"p-chlorophenylalanine: a specific depletor of brain serotonin","volume":"154","author":"Koe","year":"1966","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2009.01.006","article-title":"Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC\u2013cAMP pathway in chronic unpredictable mild stress of rats","volume":"33","author":"Li","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb9950","first-page":"1","article-title":"Alterations of serum levels of BDNF-related miRNAs in patients with depression.","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0175","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1124\/jpet.108.143610","article-title":"Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)","volume":"27","author":"Liang","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0180","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.pnpbp.2009.03.004","article-title":"Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system","volume":"33","author":"Machado","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pnpbp.2015.01.008","article-title":"Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation","volume":"59","author":"Manosso","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0190","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pnpbp.2012.12.012","article-title":"Synaptic plasticity in depression: molecular, cellular and functional correlates","volume":"43","author":"Marsden","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pbb.2014.10.010","article-title":"Antidepressant-like activity of dehydrozingerone: involvement of the serotonergic and noradrenergic systems","volume":"127","author":"Martinez","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb9955","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejphar.2004.07.038","article-title":"The role of monoamines in the actions of established and \"novel\" antidepressant agents: a critical review","volume":"500","author":"Millan","year":"2004","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb9960","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nurt.2008.10.039","article-title":"Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs","volume":"6","author":"Millan","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0200","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.pnpbp.2005.11.021","article-title":"Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients","volume":"30","author":"Mitani","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pharep.2014.09.009","article-title":"Essential elements in depression and anxiety. Part II","volume":"67","author":"M\u0142yniec","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jpsychires.2011.11.009","article-title":"Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress","volume":"46","author":"Moretti","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0215","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbr.2011.07.024","article-title":"Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test","volume":"225","author":"Moretti","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb9965","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00213-007-0728-9","article-title":"Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test","volume":"192","author":"O\u2019Leary","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb9970","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s002130051156","article-title":"Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test","volume":"147","author":"Page","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0220","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.euroneuro.2005.12.002","article-title":"Dopaminergic-based pharmacotherapies for depression","volume":"16","author":"Papakostas","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ctim.2011.12.008","article-title":"Dietary selenium and major depression: a nested case\u2013control study","volume":"20","author":"Pasco","year":"2012","journal-title":"Complement. Ther. Med."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2008.10.055","article-title":"Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system","volume":"602","author":"Posser","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0235","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(00)02490-9","article-title":"The importance of selenium to human health","volume":"356","author":"Rayman","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1039\/C3MT00185G","article-title":"Selenium biochemistry and its role for human health","volume":"6","author":"Roman","year":"2014","journal-title":"Metallomics"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0245","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.pbb.2007.09.015","article-title":"Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressant-like action","volume":"88","author":"Savegnago","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0250","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.pnpbp.2007.05.006","article-title":"Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats","volume":"31","author":"Savegnago","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0265","first-page":"201","article-title":"Depression and suicidal behavior in alcohol abusing adolescents: possible role of selenium deficiency","volume":"60","author":"Sher","year":"2008","journal-title":"Minerva Pediatr."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0270","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2005.10.002","article-title":"Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters","volume":"90","author":"Sher","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0280","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0285","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0009-3084(87)90053-3","article-title":"The role of selenium peroxidases in the protection against oxidative damage of membranes","volume":"44","author":"Ursini","year":"1987","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0290","first-page":"1","article-title":"Synthesis of alkylseleno-carbohydrates and evaluation of their antioxidant properties","volume":"00","author":"Vargas","year":"2015","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0295","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/jat.2783","article-title":"Cadmium inhibits the ovary \u03b4-aminolevulinate dehydratase activity in vitro and ex vivo: protective role of seleno-furanoside","volume":"33","author":"Vargas","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0300","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2014.09.005","article-title":"Antioxidant and antidepressant-like activities of semi-synthetic \u03b1-phenylseleno citronellal","volume":"742","author":"Victoria","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0305","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0310","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0006-3223(99)00245-0","article-title":"Genetic approaches to studying norepinephrine function: knockout of the mouse norepinephrine transporter gene","volume":"46","author":"Wang","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0320","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fct.2013.11.030","article-title":"Seleno- and telluro-xylofuranosides attenuate Mn-induced toxicity in C. elegans via the DAF-16\/FOXO pathway","volume":"64","author":"Wollenhaupt","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.pnpbp.2015.10.008_bb0325","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.pnpbp.2008.11.010","article-title":"Invivo antioxidant status: a putative target of antidepressant action","volume":"33","author":"Zafir","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461530052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461530052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:42:43Z","timestamp":1748666563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858461530052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":64,"alternative-id":["S027858461530052X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2015.10.008","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of monoaminergic system in the antidepressant-like effect of (octylseleno)-xylofuranoside in the mouse tail suspension test","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2015.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}